Oric Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Oric Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Oric Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oric Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $279k | 23k | 12.00 |
| 2025-03-31 | $2.8M | 509k | 5.58 |
| 2024-12-31 | $287k | 36k | 8.07 |
| 2024-09-30 | $236k | 23k | 10.25 |
| 2024-06-30 | $299k | 42k | 7.07 |
| 2022-03-31 | $70k | 13k | 5.34 |
| 2021-12-31 | $192k | 13k | 14.70 |
| 2021-09-30 | $273k | 13k | 20.91 |
| 2021-06-30 | $231k | 13k | 17.69 |
| 2021-03-31 | $270k | 11k | 24.50 |
| 2020-12-31 | $251k | 7.4k | 33.85 |
| 2020-06-30 | $431k | 13k | 33.73 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas